Discontinuation report MAR-SERTRALINE
Report ID | 148000 |
Drug Identification Number | 02399423 |
Brand name | MAR-SERTRALINE |
Common or Proper name | SERTRALINE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 250 BTL |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-01-24 |
Actual discontinuation date | 2018-01-24 |
Remaining supply date | 2018-01-24 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued SKU |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-10-26 | French | Compare |
v3 | 2021-10-26 | English | Compare |
v2 | 2021-10-26 | French | Compare |
v1 | 2021-10-26 | English | Compare |
Showing 1 to 4 of 4